Clorazepic Acid

CHEMBL1213252 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
314.7 g/mol
LogP
3.3
Phase
4

A benzodiazepine-related compound that acts on the central nervous system to produce calming effects. It is used to treat anxiety disorders and may also help manage withdrawal symptoms.

Berat Molekul

314,7200 g/mol

LogP

3,30

TPSA

78,80 Ų

Lipinski RO5

Lulus

Mekanisme Kerja

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, and anticonvulsant effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, …

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O

InChI

InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)

Molecular Formula

C16H11ClN2O3

HBD / HBA

2 / 4

Ikatan yang Dapat Dirotasi

2

Atom Berat

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A benzodiazepine-related compound that acts on the central nervous system to produce calming effects. It is used to treat anxiety disorders and may also help manage withdrawal symptoms.

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, and anticonvulsant effects.

Yes, Clorazepic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1213252. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2809. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.